Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Clinical Trial Analytics Services Market Analysis and Growth Forecast 2026-2032: Data Governance and Tech Innovation Transform the Global Landscape

globenewswire.com
CLVT Clarivate PLC is mentioned as a competitor in the clinical trial analytics services market. The article highlights the market's growth and technological advancements, but offers no specific sentiment towards Clarivate. CTAS Cytel Inc. is identified as a player in the clinical trial analytics services market. The article discusses the overall market's positive growth trajectory and technological transformations, without detailing specific sentiment for Cytel. ES Eurofins Scientific SE is listed as a competitor in the clinical trial analytics services market. The article focuses on the market's expansion and innovation, not providing specific sentiment for Eurofins. FTRE Fortrea Inc. is mentioned as a competitor within the clinical trial analytics services market. The article details the market's growth and the impact of technology, but does not offer specific sentiment for Fortrea. INFY Infosys Limited is mentioned as a competitor in the clinical trial analytics services market. The article focuses on the market's growth drivers and trends, not offering specific sentiment for Infosys. INSM Instem Group of Companies is listed as a competitor in the clinical trial analytics services market. The article highlights the market's expansion and technological advancements, but does not provide specific sentiment for Instem. IQV IQVIA Inc. is mentioned as a competitor in the clinical trial analytics services market. The article discusses the market's growth and innovation, but does not provide specific sentiment for IQVIA. LH Laboratory Corporation of America Holdings is listed as a competitor in the clinical trial analytics services market. The article focuses on the market's growth and technological transformation, not providing specific sentiment for Labcorp. ORCL Oracle Corporation is mentioned as a competitor in the clinical trial analytics services market. The article discusses the market's growth and innovation, but does not provide specific sentiment for Oracle. PD PPD, Inc. (by Thermo Fisher Scientific Inc.) is mentioned as a competitor in the clinical trial analytics services market. The article discusses the market's growth and innovation, but does not provide specific sentiment for PPD. QGEN QIAGEN N.V. is listed as a competitor in the clinical trial analytics services market. The article focuses on the market's expansion and technological advancements, but does not provide specific sentiment for QIAGEN. RVTY Revvity, Inc. is mentioned as a competitor in the clinical trial analytics services market. The article discusses the market's growth and innovation, but does not provide specific sentiment for Revvity. VEEV Veeva Systems Inc. is mentioned as a competitor in the clinical trial analytics services market. The article discusses the market's growth and innovation, but does not provide specific sentiment for Veeva.

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Analytics Services Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering.

The clinical trial analytics services market is evolving rapidly, driven by the increasing centrality of advanced analytics in trial management and decision-making for life sciences organizations. Robust data governance and new technology adoption are reshaping how sponsors, CROs, and research leaders approach clinical development strategies.

Market Snapshot: Clinical Trial Analytics Services Market

The Clinical Trial Analytics Services Market reached USD 6.77 billion in 2025 and is projected to rise to USD 7.56 billion by 2026. The sector anticipates a compound annual growth rate (CAGR) of 12.37%, ultimately expected to attain USD 15.32 billion by 2032. This upward trajectory reflects intensifying demand among biopharmaceutical companies, CROs, and academic organizations for tools that streamline clinical research processes, improve data transparency, and support adaptable outcomes in an environment of shifting operational and regulatory priorities across global markets.

Scope & Segmentation

This report delivers a comprehensive breakdown of the clinical trial analytics services market, highlighting core drivers, application areas, and emerging patterns among critical stakeholders:

Segment-level detail reveals where technology, local regulation, and variations in patient cohorts necessitate tailored analytics approaches that support operational excellence and regulatory compliance in clinical research.

Key Takeaways

Why This Report Matters

Key Attributes

Key Topics Covered

1. Preface

2. Research Methodology

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. Market Size & Growth Trends

3.4. Market Share Analysis, 2025

3.5. FPNV Positioning Matrix, 2025

3.6. New Revenue Opportunities

3.7. Next-Generation Business Models

3.8. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Market Outlook

4.5.1. Near-Term Market Outlook (0-2 Years)

4.5.2. Medium-Term Market Outlook (3-5 Years)

4.5.3. Long-Term Market Outlook (5-10 Years)

4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Clinical Trial Analytics Services Market, by Phase

8.1. Phase I

8.2. Phase II

8.3. Phase III

8.4. Phase IV

9. Clinical Trial Analytics Services Market, by Services

9.1. Data Management & Integrity Services

9.2. Data Visualization & Dashboarding

9.3. Patient Recruitment & Retention Analytics

9.4. Portfolio & Performance Management

9.5. Real-World Evidence (RWE) & Post-Market Surveillance

9.6. Regulatory Compliance Analytics

9.7. Risk-Based Monitoring (RBM) Services

9.8. Statistical Analysis & Reporting Services

10. Clinical Trial Analytics Services Market, by Treatment Type

10.1. Device Trials

10.1.1. Diagnostic Devices

10.1.2. Therapeutic Devices

10.2. Drug Trials

10.2.1. Biologics

10.2.2. Small Molecules

10.3. Procedural Trials

10.3.1. Radiological Procedures

10.3.2. Surgical Procedures

11. Clinical Trial Analytics Services Market, by Therapeutic Area

11.1. Cardiovascular Diseases

11.2. Neurology

11.3. Oncology

12. Clinical Trial Analytics Services Market, by End User

12.1. Academic Institutions

12.1.1. Research Hospitals

12.1.2. University Labs

12.2. Contract Research Organizations

12.3. Pharmaceutical Companies

12.3.1. Biotech Startups

12.3.2. Multinational Corporations

13. Clinical Trial Analytics Services Market, by Deployment

13.1. On-Cloud

13.2. On-Premise

14. Clinical Trial Analytics Services Market, by Region

14.1. Americas

14.1.1. North America

14.1.2. Latin America

14.2. Europe, Middle East & Africa

14.2.1. Europe

14.2.2. Middle East

14.2.3. Africa

14.3. Asia-Pacific

15. Clinical Trial Analytics Services Market, by Group

15.1. ASEAN

15.2. GCC

15.3. European Union

15.4. BRICS

15.5. G7

15.6. NATO

16. Clinical Trial Analytics Services Market, by Country

16.1. United States

16.2. Canada

16.3. Mexico

16.4. Brazil

16.5. United Kingdom

16.6. Germany

16.7. France

16.8. Russia

16.9. Italy

16.10. Spain

16.11. China

16.12. India

16.13. Japan

16.14. Australia

16.15. South Korea

17. United States Clinical Trial Analytics Services Market

18. China Clinical Trial Analytics Services Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025

19.1.1. Concentration Ratio (CR)

19.1.2. Herfindahl Hirschman Index (HHI)

19.2. Recent Developments & Impact Analysis, 2025

19.3. Product Portfolio Analysis, 2025

19.4. Benchmarking Analysis, 2025

19.5. ADM Korea Inc.

19.6. Alcura

19.7. Atorus

19.8. Caidya

19.9. Charles River Laboratories International, Inc.

19.10. Clario

19.11. Clarivate PLC

19.12. CliniMed LifeSciences

19.13. ConcertAI LLC by SymphonyAI Company

19.14. Cytel Inc.

19.15. eClinical Solutions LLC

19.16. Eurofins Scientific SE

19.17. Fortrea Inc.

19.18. Hexaware Technologies limited

19.19. ICON PLC

19.20. Infosys Limited

19.21. Insight Clinical Trial Design & Analysis

19.22. Instem Group of Companies

19.23. IQVIA Inc.

19.24. Laboratory Corporation of America Holdings

19.25. MaxisIT Inc.

19.26. MED Institute Inc.

19.27. Medidata by Dassault Systemes S.E.

19.28. Medpace, Inc.

19.29. Omega Healthcare Management Services

19.30. OpenClinica, LLC

19.31. Oracle Corporation

19.32. Parexel International (MA) Corporation

19.33. Phygital Insights

19.34. PPD, Inc. by Thermo Fisher Scientific Inc.

19.35. QIAGEN N.V.

19.36. Quanticate International Limited

19.37. Revvity, Inc.

19.38. Saama Technologies, LLC

19.39. SAS Institute Inc.

19.40. SG Analytics Pvt. Ltd.

19.41. SGS S.A.

19.42. Signant Health

19.43. SyMetric by Achiral Systems Pvt. Ltd.

19.44. Syneos Health, Inc.

19.45. Veeva Systems Inc.

19.46. Veristat LLC

For more information about this report visit https://www.researchandmarkets.com/r/7crimm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment